Related Experiment Video
Updated: Jun 21, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Genetic variation in RYR1 and malignant hyperthermia phenotypes
D Carpenter1, R L Robinson, R J Quinnell
1MH Investigation Unit, Academic Unit Anaesthesia, St James's University Hospital, Leeds LS9 7TF, UK.
Different RYR1 gene variants significantly alter malignant hyperthermia (MH) severity. This finding helps explain MH variability and guides genetic testing strategies for related conditions.
Area of Science:
- Genetics
- Pharmacology
- Medical Science
Background:
- Malignant hyperthermia (MH) is primarily linked to RYR1 gene mutations.
- The RYR1 gene encodes the skeletal muscle ryanodine receptor, crucial for muscle function.
- Understanding RYR1 variants is key to diagnosing and managing MH.
Purpose of the Study:
- To investigate the association between specific RYR1 variants and quantitative differences in the MH phenotype.
- To conduct the most extensive RYR1 genotype-phenotype correlation in MH to date.
- To correlate clinical MH presentation with laboratory findings and RYR1 genotype.
Main Methods:
- Quantitative phenotypes were generated using in vitro muscle contracture response and baseline serum creatine kinase (CK) levels.
- A large cohort of 504 individuals from 204 MH families with 23 RYR1 variants was analyzed.
- Associations between clinical, laboratory, and genotypic data were statistically determined.
Main Results:
- A novel correlation was found between in vitro muscle contracture response and clinical MH onset time (P<0.05).
- Baseline CK concentration significantly correlated with clinical onset time (P=0.039).
- Specific RYR1 variants were significant determinants of MH laboratory phenotype severity (P<0.0001).
Conclusions:
- The MH phenotype severity is significantly influenced by different RYR1 variants.
- RYR1 variants associated with severe MH are located throughout the gene at conserved protein sites.
- These genotype-phenotype differences explain MH clinical variability and potential links to rhabdomyolysis and heat stroke.
Related Concept Videos
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Epistasis
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic Variation
Genes exist in different versions called alleles, which...

